Preveon adefovir dipivoxil: A Data and Safety Monitoring Board of the National Institute for Allergy and Infectious Diseases has recommended termination of a Ph
GILD also said it completed enrollment in three studies and concluded a fourth trial. The Phase II/III trials,
